Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Roma
Clinical trial register · Italy

Clinical Trials in Roma, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6791 matching records held by the registry are in this view. Synced 11 Oct 2026, 03:19 UTC
6791
Studies in scope
all four open statuses
4079
Recruiting now
open to new participants
1019
Lead sponsors
across recruiting studies
Top sites
Milan 17 Roma 14 Naples 13 Bari 9 Florence 8
Narrow the registerReset
Recruitment status
Phase
Site location
Milan17 Roma14 Naples13 Bari9 Florence8
All 46 locations
Target enrolment
to

Trials with a site in Roma

14 of 6791 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Recruiting
Boehringer Ingelheim
Phase 3
466
Catania, Foggia, Forlì, Milan, Monza, Padova, Roma
2026-09-17
Recruiting
Boehringer Ingelheim
Phase 3
448
Ancona, Bari, Florence, Milan, Modena, Naples, Roma
2026-07-27
Recruiting
Boehringer Ingelheim
Phase 3
35
Genova, Roma
2026-07-21
Recruiting
Boehringer Ingelheim
Phase 3
390
Bari, Florence, Milan, Naples, Palermo, Roma, Verona
2026-07-10
Recruiting
A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People With a Family History of Pulmonary Fibrosis
NCT07201922Familial Pulmonary Fibrosis, Interstitial Lung Abnormalities, Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
80
Milan, Padova, Roma
2026-02-10
Recruiting
Boehringer Ingelheim
Phase 3
400
Bari, Milan, Misterbianco (CT), Naples, Orbassano (TO), Roma, Rozzano (MI), Verona
2026-01-16
Recruiting
Boehringer Ingelheim
Phase 3
120
Genova, Milan, Padova, Roma
2025-12-09
Active, closed
Boehringer Ingelheim
Phase 2
81
Bergamo, Florence, Naples, Roma, Torino
2025-11-13
Active, closed
A Study to Test Whether Nerandomilast Helps People With Lung Fibrosis Related to Rheumatic Diseases
NCT06806592Interstitial Lung Diseases, Systemic Autoimmune Rheumatic Diseases Associated Interstitial Lung Diseases
Boehringer Ingelheim
Phase 3
413
Brescia, Florence, Milan, Padova, Pavia, Roma
2025-09-13
Recruiting
Boehringer Ingelheim
Phase 3
4,200
Bergamo, Naples, Pavia, Pisa, Roma, Rozzano
2025-05-20
Recruiting
Boehringer Ingelheim
Phase 3
6,712
Bergamo, Foggia, Genova, Naples, Pavia, Roma, Rozzano
2024-06-17
Active, closed
Boehringer Ingelheim
Phase 2
190
Florence, Milan, Naples, Roma, Rozzano, Torrette Di Ancona
2024-05-15
Active, closed
Boehringer Ingelheim
Phase 3
428
Bari, Candiolo (TO), Catania, Naples, Parma, Roma, Varese
2024-02-09
Rows per page Showing 1–14 of 14
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 11 October 2026. https://priyalifescience.com/clinical-trials-italy/city/roma

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,791 studies in total at the last sync on 11 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 14 of those studies with a site in Roma that also match the filters currently applied.

How many clinical trials are recruiting in Roma?

9 of the 14 studies on this page are recruiting new participants as of the 11 Oct 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Roma), 14 studies
PhaseStudiesRecruitingShare
Phase 311978.6%
Phase 22014.3%
Phase 1/2107.1%

Most active sponsors

Lead sponsors with the most studies (Roma)
Lead sponsorStudiesRecruiting
Boehringer Ingelheim149
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.